A retrospective study of second-line platinum containing chemotherapy in patients with endometrial cancer previously treated with platinum therapy
Not Applicable
- Conditions
- uterine corpus cancer
- Registration Number
- JPRN-UMIN000005051
- Lead Sponsor
- Sankai Gynecologic Oncology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with uterine sarcoa.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method